What is the approach to treating anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Approach to Treating Anemia

The optimal approach to treating anemia requires identifying the underlying cause, investigating the etiology, and implementing appropriate iron repletion strategies based on the specific type and severity of anemia. 1

Diagnosis and Classification

  • Anemia is defined as a reduction in hemoglobin concentration, red-cell count, or packed cell volume below normal levels 1, 2
  • Severity is classified as:
    • Mild: Hb ≤11.9 g/dl and ≥10 g/dl
    • Moderate: Hb ≤9.9 and ≥8.0 g/dl
    • Severe: Hb <8.0 g/dl 1, 3
  • Initial diagnostic workup should include:
    • Complete blood count (CBC) with indices to characterize anemia 2
    • Peripheral blood smear to confirm RBC morphology 1, 2
    • Morphologic classification based on mean corpuscular volume (MCV) to identify underlying cause 2
    • Assessment for occult blood loss in stool and urine 1, 3

Treatment Algorithm by Etiology

Iron Deficiency Anemia

  • First-line therapy: Oral iron supplementation with ferrous sulfate 324 mg (65 mg elemental iron) daily or twice daily between meals 1, 3
  • Add ascorbic acid (250-500 mg twice daily) to improve iron absorption 1
  • Continue treatment for 2-3 months after hemoglobin normalization to replenish iron stores 1, 4
  • Intravenous iron therapy is indicated when:
    • Oral iron is not tolerated
    • Malabsorption is present
    • Rapid repletion is needed 1, 3
    • For patients with chronic kidney disease on hemodialysis receiving epoetin therapy 5

Anemia of Chronic Disease/Inflammation

  • Treat the underlying inflammatory condition to enhance iron absorption 2, 6
  • Consider intravenous iron in cases with active inflammation 2
  • Avoid erythropoiesis-stimulating agents (ESAs) in patients with mild to moderate anemia and heart disease 7, 2

Vitamin B12 Deficiency Anemia

  • For pernicious anemia: Intramuscular vitamin B12 100 mcg daily for 6-7 days, then alternate days for seven doses, then every 3-4 days for 2-3 weeks, followed by 100 mcg monthly for life 8
  • Administer folic acid concomitantly if needed 8

Transfusion Therapy

  • Use restrictive red blood cell transfusion strategy (trigger hemoglobin threshold of 7-8 g/dl) in hospitalized patients, particularly those with coronary heart disease 7, 1, 2
  • Reserve transfusion for severe symptomatic anemia or when rapid correction is needed 1, 3
  • Be aware of potential complications including iron overload, infection transmission, and immune suppression 1, 3

Monitoring and Follow-up

  • For iron deficiency anemia: Repeat hemoglobin measurement after 4 weeks of treatment 2, 3
  • Monitor hemoglobin levels and red blood cell indices every 3 months for 1 year and then annually 1
  • Administer additional iron supplementation if hemoglobin or MCV fall below normal 1

Common Pitfalls to Avoid

  • Failure to identify and treat the underlying cause can lead to recurrence 1, 3, 9
  • Using ESAs without considering risks including hypertension, thromboembolism, and potential tumor progression in cancer patients 1, 3
  • Overreliance on transfusions rather than addressing the underlying cause 1, 3
  • Inadequate duration of iron therapy leading to incomplete replenishment of iron stores 4
  • Neglecting to investigate gastrointestinal sources of blood loss in men and postmenopausal women with iron deficiency anemia 9

Special Considerations

  • For cancer-related anemia: Evaluate for multiple potential causes and assess factors related to production, destruction, or loss of red cells 1, 2
  • In inflammatory bowel disease: Intravenous iron therapy is recommended with active inflammation 2
  • For chronic kidney disease patients on hemodialysis: Consider ferric gluconate for iron deficiency anemia 5

References

Guideline

Approach to Treating Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Approach to Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Anemia Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of iron deficiency.

Hematology. American Society of Hematology. Education Program, 2019

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.